Neural progenitor cell (NPC) (NPC)

Neural progenitor cells (NPCs) are multipotent, self-renewing cells derived from the neuroectoderm that give rise to the primary cell lineages of the central nervous system, including neurons, astrocytes, and oligodendrocytes (Ref: NIH, Biocompare). While NPCs are most active during embryonic development, they persist throughout life in specific neurogenic niches of the adult brain, such as the subventricular zone (SVZ) and the subgranular zone (SGZ) of the hippocampal dentate gyrus (Ref: PMC). NPCs are a major focus of regenerative medicine and drug discovery, as they represent a therapeutic platform for treating neurodegenerative diseases like Alzheimer’s and Parkinson’s, as well as acute injuries such as stroke and spinal cord trauma (Ref: BioInformant, Frontiers). Current therapeutic strategies involve either the transplantation of exogenous NPCs to replace lost tissue or the pharmacological stimulation of endogenous NPC populations to promote neurogenesis and functional recovery (Ref: PMC, AACR). Pharmacological agents, including certain antidepressants, growth factors, and small molecules, are frequently studied for their ability to modulate NPC proliferation, survival, and differentiation pathways (Ref: PMC, Frontiers).

Other names

Neural stem cell (NSC)Neuronal progenitor cellNeuroblastRadial glial cellMultipotent neural progenitorIntermediate progenitor cell

Stimulation of endogenous neurogenesis; enhancement of neural progenitor cell proliferation; induction of lineage-specific differentiation into functional neurons or glia; paracrine-mediated neuroprotection through the secretion of neurotrophic factors (Ref: PMC, Frontiers).